sglt2 inhibitors vs glp 1 agonists and GLP-1 receptor agonists: a sound combination SGLT-2 inhibitors and GLP-1 receptor
Description
(2007) Incretin hormone mimetics and analogues in diabetes therapeutics

A study that investigated the effects of insulin and GLP-1RAs (exenatide and dulaglutide) on BMD over a 52-week duration gathered 70 individuals with type 2 diabetes

Semaglutide was the first GLP-1RA to meet the primary endpoint in a phase II NASH trial

There was not one I didnt like
In diabetes care, GLP-1 receptor agonists are widely integrated into treatment guidelines and reimbursement systems

Some of these use entirely different peptide structures that may be better suited to oral delivery
